Information Provided By:
Fly News Breaks for June 19, 2015
MACK, TSRO
Jun 19, 2015 | 05:40 EDT
After hosting investor meetings with management, Mizuho analyst Peter Lawson says TESARO (TSRO) remains one of the firm's favorite stocks for the second half of 2015 and beyond. Lawson sees "plenty of catalysts" for the stock, including a rolapitant launch in Q4, and believes TESARO can leverage the drug's sales force on future oncology products. He reiterates a Buy rating on the stock. Lawson also continues to likes Merrimack (MACK) after meeting with management.
News For TSRO;MACK From the Last 2 Days
There are no results for your query TSRO;MACK
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.